CERo Therapeutics Holdings, Inc.
CERO · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,304 | -$7,290 | -$11,829 | -$10,630 |
| Dep. & Amort. | $1,117 | $1,117 | $1,073 | $735 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $97 | $97 | $381 | $288 |
| Change in WC | $1,837 | $540 | $2,412 | -$365 |
| Other Non-Cash | -$537 | -$255 | $6,871 | $9,274 |
| Operating Cash Flow | -$5,790 | -$5,790 | -$1,092 | -$697 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$694 | -$613 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$14,336 | -$325 | $0 |
| Inv. Sales/Matur. | $0 | $5,639 | $0 | $0 |
| Other Inv. Act. | $0 | $8,689 | $181,859 | -$177,887 |
| Investing Cash Flow | $0 | -$8 | $180,839 | -$178,500 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$14 | $564 | $650 | $0 |
| Stock Issued | $13,728 | $0 | $0 | $180,296 |
| Stock Repurch. | $0 | -$33 | -$139,354 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$13,142 | $0 | -$139,215 | $0 |
| Financing Cash Flow | $572 | $572 | -$138,704 | $180,296 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$5,218 | -$5,218 | $41,043 | $1,099 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,820 | $6,820 | $1,099 | $29,864 |
| End Cash | $1,601 | $1,601 | $42,142 | $1,099 |
| Free Cash Flow | -$5,790 | -$5,790 | -$1,786 | -$1,310 |